NCT01302873View on ClinicalTrials.gov

Study of BGG492 in Patients With Chronic Subjective Tinnitus

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Chronic Subjective Tinnitus
Interventions
DRUG

BGG492A

DRUG

BGG492A

Trial Locations (4)

9700

Novartis Investigative Site, Groningen

10117

Novartis Investigative Site, Berlin

Unknown

Novartis Investigative Site, Frankfurt

Novartis Investigative Site, Lepzig

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY